Generic Version

Type: Keyphrase
Name: Generic Version
First reported Sep 19 2014 - Updated 16 hours ago - 1 reports

United States : US FDA declares final permit to deal with Aurobindo's generic anti-infective drug in AMERICA [TendersInfo (India)]

The US Food & Drug Administration (USFDA) announced releasing final approval to yield as well as merchandise Aurobindo Pharma s generic version of Amoxicillin for oral suspension for dealing with infections in the American market.For oral suspension, ... [Published Pharmacy Choice - Sep 19 2014]
First reported Sep 19 2014 - Updated Sep 19 2014 - 1 reports

Brazilian drug regulator to consider relaxing norms for Indian firms

Brazil, one of the key export markets in Latin America for Indian pharma companies, is reviewing the proposal to allow Indian laboratories to conduct bioequivalence tests, necessary to grant product approvals in that country.Senior officials from the ... [Published Business Standard India - Sep 19 2014]
First reported Sep 19 2014 - Updated Sep 19 2014 - 1 reports

Gynest discontinuation

Gynest cream (estriol) 0.01% with applicator, 80g pack, is being discontinued by Marlborough Pharmaceuticals. A generic version of the product is available from Sovereign Medical. Further information on 01268 594774.Citation: The Pharmaceutical Journal ... [Published Pharmaceutical Journal - Sep 19 2014]
First reported Sep 19 2014 - Updated Sep 19 2014 - 1 reports

Rite Aid cuts earnings forecast

advertisement | your ad hereBloomberg NewsNEW YORK — Rite Aid Corp. reduced its full-year earnings forecast after it said lower reimbursement rates and higher costs for drugs hurt profit.Net income for fiscal 2015 is expected to be 22 cents to 33 cents ... [Published HeraldNet - Sep 19 2014]
First reported Sep 17 2014 - Updated Sep 18 2014 - 3 reports

Gilead Sciences: The Recent Dip In Share Price Creates A Buying Opportunity

Summary Gilead Sciences's stock has been on a rocket ship trajectory ever since the launch of its blockbuster drug, Sovaldi. Gilead Sciences is planning to launch a generic version of the Sovaldi drug for more than 90 developing countries. Sovaldi's ... [Published Seeking Alpha - Sep 18 2014]
First reported Sep 18 2014 - Updated Sep 18 2014 - 1 reports

Mylan to Test Generic Version of Advair Diskus

Mylan will conduct a phase 3 clinical trial to evaluate the equivalence of its generic version of Advair Diskus as inhalation treatment in adults with asthma, according to a press release.The randomized, double blind, double-dummy, parallel group study ... [Published RT Magazine - Sep 18 2014]
First reported Sep 18 2014 - Updated Sep 18 2014 - 1 reports

Cramer: Good news for tech names

Behind the scenes, I think a lot of the big funds have learned their allocation on the Alilbaba initial public offering, and that they don't need to sell much more in other stocks to get as much Alibaba as they need in the after-market. This is good news, ... [Published Option Monster - Sep 18 2014]
First reported Sep 17 2014 - Updated Sep 18 2014 - 1 reports

Mylan to test generic version of Advair Diskus for asthma treatment

Mylan will conduct a phase 3 clinical trial to evaluate the equivalence of its generic version of Advair Diskus as inhalation treatment in adults with asthma, according to a press release.The randomized, double blind, double-dummy, parallel group study ... [Published Orthopedics Today - Sep 17 2014]
First reported Sep 16 2014 - Updated Sep 16 2014 - 3 reports

Mylan To Commence Phase III Trial For Its Generic Version Of Advair Diskus

CANONSBURG (dpa-AFX) - Mylan Inc. (MYL) announced it is initiating Phase III clinical trials for its generic version of GlaxoSmithKline's Advair Diskus and its insulin analog to Sanofi's Lantus. Two Phase III clinical trials for Mylan's insulin analog ... [Published FinanzNachrichten.de - Sep 16 2014]
First reported Sep 16 2014 - Updated Sep 16 2014 - 1 reports

No quality control for life-saving generic drugs, govt apathetic

NEW DELHI: While the Indian government is pushing generic drugs as they are cheaper and, therefore, more affordable, there seems to inadequate attention on ensuring that the quality protocol of these drugs is properly observed.A case in point is a life-saving ... [Published Times of India - Sep 16 2014]
First reported Sep 15 2014 - Updated Sep 15 2014 - 2 reports

Midday movers: Apple, Netflix, RadioShack & more

Take a look at some of Monday's midday movers:Alere ( ALR ) - The supplier of health services gained after its former CEO said in a regulatory filing that he was working to take it private.Ann ( ANN ) - The women's retailer declined as two hedge funds ... [Published Yahoo! Finance - Sep 15 2014]
First reported Sep 15 2014 - Updated Sep 15 2014 - 3 reports

Gilead to license generic version of Sovaldi

Gilead Sciences has reached a deal with several generic drugmakers to produce cheaper versions of its popular, expensive hepatitis C drug Sovaldi for use in developing countries. Gilead said Monday that the India-based drugmakers will make a generic ... [Published The Washington Times stories: News - Sep 15 2014]

Quotes

...that officials from the ANVISA, the national health surveillance agency of Brazil, might soon visit India to interact with CDSCO officials. "The ball has been set in motion. Things are moving very fast" he claimed
Aurobindo said in a statement: "This Abbreviated New Drug Application (ANDA) has been approved out of Unit XII, Semi-Synthetic Penicillin (SSP) formulation facility in Hyderabad India."
...pain and also result in meaningful improvements in patient function," said Charles Argoff, M D , Professor of Neurology, Albany Medical College. "This post-hoc analysis showed that approximately 44% of patients taking Zohydro ER achieved a level of pain relief that was also associated with a significant improvement in their ability to, once again, conduct normal life activities."
...of two cords concurrently and delayed finger extension" said Adrian Adams , Chief Executive Officer and President of Auxilium Pharmaceuticals. "We are looking forward to our PDUFA date in October and if approved, we believe that two concurrent XIAFLEX injections may allow more rapid overall treatment of multiple affected joints, without the need to wait approximately four weeks between treatments as required in the current labeling."

More Content

All (638) | News (460) | Reports (0) | Blogs (169) | Audio/Video (0) | Fact Sheets (0) | Press Releases (7)
sort by: Date | Relevance
Global watchdogs take on the corporate tax dodgers [Published Globe and Mail - 15 hours ago]
5 Things Rite Aid Corporation's Management Want... [Published Motley Fool - Sep 19 2014]
Brazilian drug regulator to consider relaxing n... [Published Business Standard India - Sep 19 2014]
Gilead Emerging Market Agreement: Huge Win For ... [Published Seeking Alpha - Sep 19 2014]
India's Drug War Is Good News [Published Bloomberg View - Sep 19 2014]
Gynest discontinuation [Published Pharmaceutical Journal - Sep 19 2014]
United States : US FDA declares final permit to... [Published Pharmacy Choice - Sep 19 2014]
Rite Aid cuts earnings forecast [Published HeraldNet - Sep 19 2014]
Mealey's PI/Product Liability - Pa. High Court ... [Published Mealey - Sep 18 2014]
Mylan to Test Generic Version of Advair Diskus [Published RT Magazine - Sep 18 2014]
Gilead Sciences: The Recent Dip In Share Price ... [Published Seeking Alpha - Sep 18 2014]
Cramer: Good news for tech names [Published Option Monster - Sep 18 2014]
8 Items You Should Always Buy Generic [Published US News & World Report - Sep 18 2014]
What Makes Mylan Attractive [Published Seeking Alpha - Sep 18 2014]
New Data Shows Zohydro(R) ER Reduced Pain and I... [Published Stock Nod - Sep 18 2014]
Auxilium Pharmaceuticals, Inc. Presents XIAFLEX... [Published A.M. Best - Sep 18 2014]
India,United States : EPIRUS gets approval for ... [Published Pharmacy Choice - Sep 18 2014]
Indian stock market daily morning report (Septe... [Published Stock Markets Review - Sep 18 2014]
Mylan initiates phase III trials of generic Adv... [Published PharmaBiz - Sep 18 2014]
Ranbaxy Nexium Generic Still Not Launched Despi... [Published Health News Daily - Sep 18 2014]
Generic Version of Pricey Hep C Drug Available ... [Published Fix.com - Sep 17 2014]
Mylan to test generic version of Advair Diskus ... [Published Orthopedics Today - Sep 17 2014]
India Must Fix Its Drug Quality Problem [Published Forbes.com - Sep 17 2014]
Momenta Pharmaceuticals to Webcast Presentation... [Published GlobeNewswire: Acquisitions News - Sep 17 2014]
Momenta Pharmaceuticals to Webcast Presentation... [Published MoneyShow.com - Sep 17 2014]
US FDA approves Aurobindo’s generic anti-infect... [Published PBR - News - Sep 17 2014]
Sensex off from highs; top twelve stocks in focus [Published Economic Times - Sep 17 2014]
Aurobindo Pharma jumps 3%, gets USFDA nod for A... [Published Moneycontrol.com - Sep 17 2014]
Aurobindo Pharma gains after USFDA nod for Amox... [Published Business Standard India - Sep 17 2014]
Indian Stocks Likely To Open Higher [Published RTTNews.com - Sep 17 2014]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
US FDA approves Aurobindo’s generic anti-infect... [Published PBR - News - Sep 17 2014]
The US Food & Drug Administration (USFDA) has issued final approval to produce and market Aurobindo Pharma’s generic version of Amoxicillin for oral suspension to treat infections in the American market. ...
BioNews [9.16.14] [Published eClinical Trends - Sep 16 2014]
Top News HeadlineCompanyType Human Hair Discovered In Heparin Vial Prompts Hospira, Inc. Recalls Hospira, Inc.Vial Recalls NovaBay Pharmaceuticals, Inc. Will Feature i-Lid Cleanser For The First Time At Vision Expo West NovaBay Pharmaceuticals, ...
Mylan Commences Phase III Clinical Trials for i... [Published PR Newswire: Health - Sep 16 2014]
PITTSBURGH, Sept. 16, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL), one of the world's leading global pharmaceutical companies, today announced it is initiating Phase III clinical trials for its generic version of GlaxoSmithKline's Advair Diskus® ...
The new drug wars: Brand-name pharma giants att... [Published National Post - Top Stories - Sep 14 2014]
The invitation to the dinner and talk for health professionals at Solo Trattoria in Sault Ste. Marie, Ont., simply posed questions. “Generic medications: are they really equal,” the notice asked, and “Do generics help or hinder patient care?” The answers ...
One Reason to Not Use Generic Medicines [Published Freakonomics - Sep 12 2014]
Our latest podcast episode — “ How to Save $1 Billion Without Even Trying ” — discusses research which finds that health-care experts generally buy generic medicines for their own use rather than the more expensive name brands. The episode discusses ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
Momenta Pharmaceuticals to Webcast Presentation... [Published GlobeNewswire: Acquisitions News - Sep 17 2014]
Mylan Wins Motion to Enjoin GlaxoSmithKline fro... [Published Financial Services - Jul 17 2014]
Milan District Court Confirms the Validity of A... [Published Financial Services - Jun 12 2014]
ACETO Subsidiary Rising Pharmaceuticals Launche... [Published GlobeNewswire: Acquisitions News - Jun 11 2014]
CorePharma, LLC Announces the Launch of Dextroa... [Published Financial Services - Jun 04 2014]
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.